Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Showing 20 of 0 results

Not applicableStudy completedNCT00176033
What this trial is testing

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

Who this might be right for
HealthyPharmacokinetics
Heidelberg University 12
Post-approval studies (Phase 4)Ended earlyNCT00386659
What this trial is testing

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 60
Not applicableUnknownNCT01705873
What this trial is testing

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Who this might be right for
HIVHypercholesterolemiaDyslipidemia
Helios Salud 300
Not applicableStudy completedNCT00571961
What this trial is testing

Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)

Who this might be right for
HIV Infections
Yale University 12
Early research (Phase 1)Study completedNCT00766818
What this trial is testing

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

Who this might be right for
PregnancyHIV
University of North Carolina, Chapel Hill 12
Not applicableStudy completedNCT01075191
What this trial is testing

Kaletra: Therapy With Double Protease Inhibitors

Who this might be right for
Human Immunodeficiency Virus
AbbVie (prior sponsor, Abbott) 65
Early research (Phase 1)Study completedNCT07002242
What this trial is testing

A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Aluvia

Who this might be right for
Healthy
Henan Genuine Biotech Co., Ltd. 15
Early research (Phase 1)Study completedNCT00531999
What this trial is testing

Raltegravir Insulin Sensitivity Study

Who this might be right for
HIV Infections
St Stephens Aids Trust 18
Post-approval studies (Phase 4)Study completedNCT00865475
What this trial is testing

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Who this might be right for
HIV InfectionHIV Infections
Fundacion SEIMC-GESIDA 38
Post-approval studies (Phase 4)Study completedNCT01576731
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Post-approval studies (Phase 4)Study completedNCT00865007
What this trial is testing

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Who this might be right for
HIV InfectionLipodystrophyHIV Infections
Fundacion SEIMC-GESIDA 88
Not applicableStudy completedNCT02581202
What this trial is testing

The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

Who this might be right for
HIV-1 Infection
AbbVie 216
Early research (Phase 1)Study completedNCT00833378
What this trial is testing

Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.

Who this might be right for
Hepatitis C
GlaxoSmithKline 40
Early research (Phase 1)Study completedNCT00920088
What this trial is testing

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 24
Post-approval studies (Phase 4)Study completedNCT00335686
What this trial is testing

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 67
Large-scale testing (Phase 3)Study completedNCT00424814
What this trial is testing

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 105
Not applicableStudy completedNCT01076972
What this trial is testing

Drug Use Investigation of Kaletra

Who this might be right for
Human Immunodeficiency Virus
Abbott 1,184
Early research (Phase 1)Study completedNCT00828529
What this trial is testing

TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

Who this might be right for
TuberculosisHIV
Tibotec BVBA 16
Post-approval studies (Phase 4)Study completedNCT00785616
What this trial is testing

A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence

Who this might be right for
HIV Infection
Montefiore Medical Center 55
Testing effectiveness (Phase 2)WithdrawnNCT04455958
What this trial is testing

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
OHSU Knight Cancer Institute
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation